Which Thrombophilia Tests Really Matter? – ICHCC
Iranian Comprehensive Hemophilia Care Center (ICHCC) shared a post on LinkedIn:
“Thrombophilia Testing: Which Tests Really Matter?
Although thrombophilia panels are frequently requested, not all tests provide the same clinical value. Current guidelines emphasize identifying thrombophilic conditions with proven impact on patient management.
Key Tests for Inherited Thrombophilia
- Factor V Leiden Mutation
The most common inherited thrombophilia in many populations.
- Prothrombin G20210A Mutation
The second most common inherited genetic risk factor for venous thrombosis.
- Protein C Activity
Deficiency is associated with an increased risk of venous thromboembolism (VTE).
- Protein S Activity
Both inherited and acquired deficiencies may predispose to thrombosis.
- Antithrombin Activity
One of the highest-risk inherited thrombophilic disorders.
Key Tests for Acquired Thrombophilia
- Lupus Anticoagulant (LA)
- Anticardiolipin Antibodies (aCL IgG/IgM)
- Anti-β2 Glycoprotein I Antibodies
These three tests form the cornerstone of diagnosing Antiphospholipid Syndrome (APS).
Which Tests Are Less Useful Today?
- MTHFR mutation testing
- Homocysteine levels (in most patients)
- PAI-1 4G/5G polymorphism
- Various low-impact genetic polymorphisms
In most cases, these tests do not alter clinical management.
When Should Testing Be Performed?
- During an acute thrombotic event
- While receiving warfarin, heparin, or DOAC therapy
These situations may lead to inaccurate results.
Ideally, testing should be performed several weeks after the acute event and, when feasible, after anticoagulation has been discontinued.
Clinical Pearl
For most patients, a focused thrombophilia workup including:
- Factor V Leiden
- Prothrombin G20210A
- Antithrombin
- Protein C
- Protein S
- APS Panel
Provides far more clinically meaningful information than broad, expensive thrombophilia panels.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 16:26Ifeanyichukwu Ifechidere: A Prolonged APTT Is Not Always a Bleeding Disorder
-
Jun 23, 2026, 15:36Arun V. J.: Transforming Transfusion Medicine Through Leadership Development
-
Jun 23, 2026, 15:32Wolfgang Miesbach: Liver Organoids Advance the Future of AAV Gene Therapy Safety Testing
-
Jun 23, 2026, 15:27Shadi Tabibian: A New Era in von Willebrand Disease Treatment
-
Jun 23, 2026, 15:13Ibré Gallardo: Shifting Paradigms in AFIB Therapeutics
-
Jun 23, 2026, 14:26James Crowley: The Hidden Burden of Atrial Fibrillation
-
Jun 23, 2026, 14:15Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation
-
Jun 23, 2026, 13:44How Sickle Hemoglobin Fuels Thrombosis and Vascular Injury – JTH
-
Jun 23, 2026, 13:30Amit Malhotra: The Expanding Role of Upadacitinib Across Autoimmune and Inflammatory Disorders